STOCKHOLM, Sweden--(BUSINESS WIRE)--The biopharma company Biovitrum (STO:BVT), listed on the Stockholm Stock Exchange since September 15, 2006, invites media and analysts to a press- and analyst meeting in Stockholm and conference call on Tuesday November 14 in conjunction with the disclosure of the interim report for January-September 2006. The report is scheduled for publication at 08:30 (CET) on the same date.
